Relationship between clinical macular changes and retinal function in age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 9, 2012, Pages 5213-5220

  Dimitrov, Peter N ^a   Robman, Liubov D ^a   Varsamidis, Mary ^a   Aung, Khin Zaw ^a   Makeyeva, Galina ^a   Busija, Lucy ^a   Vingrys, Algis J ^a   Guymer, Robyn H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EYE FUNDUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; STAGING; TREATMENT OUTCOME; VISION; VISUAL ACUITY; AGED; FEMALE; OPTIC DISK ANOMALY; PATHOLOGY; PATHOPHYSIOLOGY; PHOTORECEPTOR CELL; PHYSIOLOGY; PIGMENT EPITHELIUM; PROGNOSIS; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA;

AGED; FEMALE; FUNDUS OCULI; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; OPTIC DISK DRUSEN; PHOTORECEPTOR CELLS, VERTEBRATE; PIGMENT EPITHELIUM OF EYE; PROGNOSIS; VISUAL ACUITY;

EID: 84867841532     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8958     Document Type: Article

References (44)

1. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39: 367-374.
2. Davis MD, Gagnon RE, Lee LY, et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123: 1484-1498.
3. van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol. 2003;121:519-526.
4. Klaver CC, Assink JJ, van Leeuwen R, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2001;42:2237-2241.
5. Wang JJ, Foran S, Smith W, Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol. 2003;121:658-663.
6. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam eye study. Ophthalmology. 2002;109:1767-1779.
7. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
8. Ferris FL, Davis MD, Clemons TE, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123:1570-1574.
9. Stanga PE, Bird AC. Optical coherence tomography (OCT): principles of operation, technology, indications in vitreoretinal imaging and interpretation of results. Int Ophthalmol. 2001; 23:191-197.
10. Lois N, Owens SL, Coco R, Hopkins J, Fitzke FW, Bird AC. Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss. Am J Ophthalmol. 2002;133:341-349.
11. Neelam K, Nolan J, Chakravarthy U, Beatty S. Psychophysical function in age-related maculopathy. Surv Ophthalmol. 2009; 54:167-210.
12. Dimitrov PN, Robman LD, Varsamidis M, et al. Visual function tests as potential biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;51:9457-9469.
13. Casswell AG, Kohen D, Bird AC. Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol. 1985;69:397-403.
14. Cukras C, Agron E, Klein ML, et al. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28. Ophthalmology. 2010;117:489-499.
15. Taylor HR, West SK. The clinical grading of lens opacities. Aust N Z J Ophthalmol. 1989;17:81-86.
16. Aung KZ, Robman L, Chong EW, English DR, Giles GG, Guymer RH. Non-mydriatic digital macular photography: how good is the second eye photograph? Ophthalmic Epidemiol. 2009;16:254-261.
17. Scholl HP, Dandekar SS, Peto T, et al. What is lost by digitizing stereoscopic fundus color slides for macular grading in age-related maculopathy and degeneration? Ophthalmology. 2004; 111:125-132.
18. Dimitrov PN, Guymer RH, Zele AJ, Anderson AJ, Vingrys AJ. Measuring rod and cone dynamics in age-related maculopathy. Invest Ophthalmol Vis Sci. 2008;49:55-65.
19. Phipps JA, Guymer RH, Vingrys AJ. Loss of cone function in age-related maculopathy. Invest Ophthalmol Vis Sci. 2003;44: 2277-2283.
20. Owsley C, Jackson GR, Cideciyan AV, et al. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:267-273.
21. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1236-1249.
22. Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001;108:1196-1202.
23. Gittings NS, Fozard JL. Age related changes in visual acuity. Exp Gerontol. 1986;21:423-433.
24. Eisner A, Stoumbos VD, Klein ML, Fleming SA. Relations between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 1991;32:8-20.
25. Beirne RO, Hogg RE, Stevenson MR, Zlatkova MB, Chakravarthy U, Anderson RS. Severity staging by early features of agerelated maculopathy exhibits weak relationships with functional deficits on SWS grating acuity. Invest Ophthalmol Vis Sci. 2006;47:4624-4631.
26. Collins M, Brown B. Glare recovery and its relation to other clinical findings in age-related maculopathy. Clin Vision Sci. 1989;4:155-163.
27. Cheng AS, Vingrys AJ. Visual losses in early age-related maculopathy. Optom Vis Sci. 1993;70:89-96.
28. Sunness JS, Massof RW, Bressler NM, Bressler SB. S cone pathway sensitivity in eyes with high risk and low risk drusen characteristics. Appl Opt. 1989;28:1158-1164.
29. Bird, AC. Bruch's membrane change with age. Br J Ophthalmol. 1992;76:166-168.
30. Guymer R, Luthert P, Bird A. Changes in Bruch's membrane and related structures with age. Prog Retin Eye Res. 1999;18: 59-90.
31. Lamb TD, Pugh EN Jr. Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res. 2004;23:307-380.
32. Pianta M, Kalloniatis M. Characterisation of dark adaptation in human cone pathways: an application of the equivalent background hypothesis. J Physiol. 2000;528:591-608.
33. Formaz F, Riva CE, Geiser M. Diffuse luminance flicker increases retinal vessel diameter in humans. Curr Eye Res. 1997;16:1252-1257.
34. Garhöfer G, Zawinka C, Resch H, Huemer KH, Dorner GT, Schmetterer L. Diffuse luminance flicker increases blood flow in major retinal arteries and veins. Vision Res. 2004;44:833-838.
35. Shakoor A, Blair NP, Mori M, Shahidi M. Chorioretinal vascular oxygen tension changes in response to light flicker. Invest Ophthalmol Vis Sci. 2006;47:4962-4965.
36. Friedman E. Update of the vascular model of AMD. Brit J Ophthalmol. 2004;88:161-163.
37. Friedman E, Krupsky S, Lane AM, et al. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology. 1995;102:640-646.
38. Chen JC, Fitzke FW, Pauleikhoff D, Bird AC. Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci. 1992;33:334-340.
39. Pauleikhoff D, Chen JC, Chisholm IH, Bird AC. Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol. 1990;109:211-217.
40. Ciulla TA, Harris A, Chung HS, et al. Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration. Am J Ophthalmol. 1999;128:75-80.
41. Bird AC. Doyne Lecture. Pathogenesis of retinal pigment epithelial detachment in the elderly; the relevance of Bruch's membrane change. Eye (Lond). 1991;5:1-12.
42. Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CB. Mid-frequency loss of foveal flicker sensitivity in early stages of age-related maculopathy. Invest Ophthalmol Vis Sci. 1992;33:3136-3142.
43. Phipps JA, Dang TM, Vingrys AJ, Guymer RH. Flicker perimetry losses in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45:3355-3360.
44. Feigl B, Brown B, Lovie-Kitchin J, Swann P. Functional loss in early age-related maculopathy: the ischaemia postreceptoral hypothesis. Eye. 2007;21:689-696.